Skip to main content
. 2007 Aug 7;97(5):670–677. doi: 10.1038/sj.bjc.6603907

Figure 6.

Figure 6

Disease-specific survival rates were significantly different for patients with low (− or +) and high (++ or +++) levels of CCR7 immunostaining (P=0.0062).